Order Article Reprints

Bastos Oreiro M, Martín R, Gomez P, López Muñoz N, Rodriguez A, Liébana M, Navarro B, Sánchez-González B, Marí P, Pérez de Oteiza J, et al. SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment. Cancers. 2021; 13(10):2412. https://doi.org/10.3390/cancers13102412

Bastos Oreiro, Mariana, Reyes Martín, Pilar Gomez, Nieves López Muñoz, Antonia Rodriguez, Marta Liébana, Belén Navarro, Blanca Sánchez-González, Pilar Marí, Jaime Pérez de Oteiza, and et al. 2021. "SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment" Cancers 13, no. 10: 2412. https://doi.org/10.3390/cancers13102412

Bastos Oreiro, M., Martín, R., Gomez, P., López Muñoz, N., Rodriguez, A., Liébana, M., Navarro, B., Sánchez-González, B., Marí, P., Pérez de Oteiza, J., Gutiérrez, A., Bento, L., Domingo Doménech, E., Vidal, M. J., Del Campo, R., Pérez Ceballos, E., Infante, M., Roldán, A., García Belmonte, D., ... on behalf of the GELTAMO Group. (2021). SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment. Cancers, 13(10), 2412. https://doi.org/10.3390/cancers13102412